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Abstract
Autoimmune diseases have gender bias with predominance in females, autoimmune infer-
tility (AI) being no exception. This chapter will focus on AI in females with brief reference to
the same in males. Autoimmune diseases have established protocols for detection and
management of ensuing infertility, however similar protocols for unexplained infertility
[tubal blockage, endometriosis, premature ovarian insufficiency (POI), undiagnosed under-
lying autoimmune disease (Sjögren’s syndrome, IBS, celiac disease) and tubal blockage] are
not established. Endometriosis and POI, in particular, have autoimmune etiology yet lack
specific and sensitive biomarkers for accurate diagnosis. If autoantibodies are indeed diag-
nosed, then treatment regimen focuses on AI which has known adverse effects. The detec-
tion of natural antibodies as autoantibodies presents a viable alternative to organ specific
biomarker panel for better management of AI.
Keywords: autoantibodies, premature ovarian insufficiency, endometriosis, autoimmune
infertility
1. Introduction
As per immunculus concept, natural antibodies (NAbs) are formed in response to gut microflora
and environment in addition to self-antigens through feedback network to maintain homeostasis
[1–3] bridging innate and adaptive immune response. Thus, any chronic inflammation com-
bined with compromised central tolerance can culminate into autoimmune disease [4]. However,
autoimmune diseases have gender bias with prevalence in females owing to ‘autoimmune X
chromosome’ and autoimmune infertility (AI) is no exception [5]. Concomitantly, reproductive
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autoimmune failure could result from an activated immune system or by anti-ovarian antibodies
(AOA) alone as described in endometriosis patients [6]. Other reproductive disorders such as
POI, polycystic ovary syndrome (PCOS), unexplained infertility, and repeatedly unsuccessful
IVF attempts may be responsible for the pathophysiology of preeclampsia or spontaneous
abortions and may also have presence of multiple autoantibodies (AAbs) [7–11].
Immune dysregulation is the cause of unexplained or idiopathic infertility in 20–30% of
infertile couples [12]. AI is diagnosed when spontaneously synthesized antibodies bind or
react with sperm/oocyte to prevent any one or several events: fertilization, acrosome reaction,
capacitation or embryo implantation. Despite much research into organ specific biomarkers,
no specific and sensitive biomarkers have been identified making detection of AI elusive.
Organ-specific autoimmune disease gets treated using established protocols without sufficient
consideration for fertility of women. Detection of AAbs mandates management of endometri-
osis, POI and other idiopathic infertility as an autoimmune disease with the treatment having
adverse effects. This chapter will focus on AI, briefly in males but mainly in females, to
include:
1. autoantigenic targets identified in female infertility with special emphasis on endometri-
osis and POI,
2. current understanding of effect of autoantibodies using animal models of disease,
3. including (AAbs) as diagnostic tools: current practices and
4. future research.
2. Male autoimmune infertility: anti-sperm antibodies (ASA)
Sperm are specialized haploid cells with autoantigenic and isoantigenic potential. Thus, ASA
can be present in blood, semen, follicular fluid and cervicovaginal secretions affecting sperm
movement, capacitation, fertilization and embryo implantation [13, 14]. ASA are far more
frequent than oocyte antibodies.
In testis, the Sertoli cells through tight junctions form the impervious blood-testis barrier of
two compartments: basal and adluminal. Basal compartment, which houses spermatogonia
and young spermatocytes, is connected to vasculature through phagocytic Sertoli cells, which
in turn act as antigen presenting cells to induce tolerance. The adluminal surface housing
sperm undergoing meiosis and spermiogenesis is segregated from vasculature. Thus leakage
of autoantigens from basal compartment can potentially generate ASAs. However, the exact
mechanism of ASA generation is still unclear [13]. In some cases, Human Leucocyte Antigen
system is associated with ASA and AI [15]. In 0.9–4% of normal fertile adult males as well as
pre-pubertal boys, ASA are found in blood serum, seminal plasma, or directly attached to
sperm surface indicating these to be NAbs generating confusion on their role in human
infertility [16, 17].
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Very few ASA are sperm specific [18] and never directed to multiple organs (except in ani-
mals). These can appear more frequently due to testicular failures: cryptorchidism, unde-
scended testes, mobile testes and orchitis (especially due to infectious diseases such as
mumps). Additionally, varicocele increases the risk of ASA production by two-fold [19]. The
reduced testosterone levels due to altered Leydig cell function in undescended testes could
theoretically result in reduced T regulatory cells and compromised central tolerance, however,
exact mechanism is unclear. Elevated ASA could lead to low sperm count or low progressive
motility. Hence, surgery at an early age, followed by steroid therapy to suppress immune
reaction is recommended to prevent future infertility in cases with testicular failure.
ASA could be against carbohydrate moieties and sperm antigens example integral membrane
proteins (exposed due to undescended testes) mainly through molecular mimicry. Natural
ASA are reported in rodents due to sperm antigenic ‘leak’ to ensure immune tolerance. ASA
are generally associated with genital tract infections. Vasectomy induces AAbs to antigens of
mature human sperm [20, 21] with HLABw22 and A28 having increased predisposition post
vasectomy [22]. Incidence reported is 61% pre- and 73–80% post-vasectomy. Antigens could be
of either testicular or epididymal origin (epididymal maturation) with Abs directed to acro-
some, equatorial and postacrosomal regions, tail midpiece and sperm nucleus. This could be
due to sperm leakage in either the vas or cauda epididymis [21]. AutoAbs to FA-1 antigen
(44%) and protamine (28%) seen post vasectomy in sera (none in seminal plasma) with preva-
lence of reduced fertilization rate in vitro. These were either of IgG, M or A subclass [23]. Post
vasectomy ASA are seen only in serum while in seminal plasma and ejaculate post
vasovasostomy. Fertile men with no ASA before vasovasostomy will show ASA that can affect
sperm count [24, 25]. Further, there is no overlap of ASA between infertile men, post vasec-
tomy [26] and post vasovasostomy. However, there are conflicting reports on their influence on
pregnancy rate [27, 28]. Table 1 enlists ASA in men with autoimmune infertility.
High titers of IgA-ASA found in seminal plasma of infertile men bind sperm head and impair
fertilizing ability, the IgG elicit opsonization, and IgM from vaginal washings of vaginitis cases
reduce fertilization by 44% [13]. ASAs directed to surface antigens are clinically relevant since
they affect semen quality (not morphology or count) by any one of: premature acrosome
reaction making the sperm moribund, sperm agglutination leading to impairment in cervical
mucus penetration, opsonization through female genital tract via complement pathway.
ASA may aid sperm capacitation with no adverse effects on sperm-oocyte fusion. However,
ASA binding outer acrosomal membrane proteins are washed away during procedure and do
not affect IVF-intracytoplasmic sperm injection (IVF-ICSI) outcomes unlike those in females
which are reported to reduce cleavage rate [47–49], with multiple autoantigenic targets neces-
sary for AI [50].
Typically in women, the mucosal immunity protects entire reproductive tract up to Fallopian
tubes against incoming sperm or any microbes. Thus vaginal and cervical secretions may
contain ASA due to multiple semen exposures causing autoantigenicity to seminal fluid pro-
teins. In rare cases of Human Seminal Plasma Allergy, first exposure can elicit antibodies [51]
though it is not always associated with infertility [52, 53].
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ASA in females are of IgG, IgA and IgE subtypes in blood, lymph and cervical-vaginal mucus
[50]. IgA antibodies in the cervical secretions can bind and agglutinate sperm with eventual
clearance by circulating macrophages while the predominant IgG [54] can lead to opsonization




Nuclear autoantigenic sperm protein (NASP)
histone binding
Serum Lowers fertilization rate [29]




YLP 12 peptide Serum acrosome reaction, union of sperm-
oocyte
[32]
HSP70, 70-2 and 90 Serum Acrosome reaction [26]
Disulfide isomerase ER60 – – [26]
Sperm agglutination antigen-1 (SAGA-1) – – [33]
Alpha enolase Serum – [34]
Rab GDP-dissociation inhibitor beta –





L-Lactate dehydrogenase C chain –
ATP synthase beta chain mitochondrial precursor –




ESP Serum Intra-acrosomal [35]
SAMP 32 [36, 37]
SAMP14/ PH-20/hyaluronidase [38]




RSP44 A radial spoke protein present in the
axonemes of both sperm tail and cilia
[43]
FSP95 Fibrous sheath antigen [44]
SLLP1 Intra-acrosomal protein [44]
Zona pellucida [8]
FSH [45]
hESP Serum Sperm-egg binding and fusion [46]
Table 1. List of autoantigens in men with autoimmune infertility.
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protected by circulating macrophages and NK cells that clear the incoming sperm. Thus sperm
coated with IgA-ASA are unaffected unlike those by IgG which are opsonized and cleared via
macrophages. Both subtypes in the mucus individually affect fertilization alone while a com-
bination significantly affects fertilization rate [55–58].
IgA alloantibodies to FSH are seen in some normal fertile women and can be produced during
tolerance to partner antigens (sperm proteins and shared maternal antigens) through semen
[59, 60]. Patients with increased intestinal permeability in bowel inflammatory disease show
higher production of ASA through molecular mimicry or epitope sharing between intestinal
microbes and spermatozoa [61]. An upregulated normal mucosal immune response could lead
to the elevated levels of anti-FSH IgA antibodies in IVF patients. Another possible explanation
could be a deficit in producing antibodies that neutralize anti-FSH immunoglobulins, which
has been noted in patients who produce ASA [62]. These results together suggest that the
elevated values of anti-FSH IgA in IVF patients could represent a failure in mucosal tolerance
in the genital tract, which could be genetically determined [12] (Table 2). Enlists ASA detected
in sera of women.
2.1. Diagnostic approaches and treatment modalities for couples with ASA
Presence of ASA in serum of seminal fluid binding to sperm outer membrane antigens and
thereby altering fertilization rate are relevant, is inversely correlated with pregnancy and not a
good indicator of pregnancy outcome. Testing for ASA is indicated for men with genitourinary
infections (e.g., Chlamydia) or acquired genital tract obstructions. Nevertheless, these ASA
may not always hinder pregnancy.
Sexually active homosexual individuals who have also undergone pelvic surgery should be
advised to test for ASA [69]. Routine semen samples can be tested for sperm bound antibodies
by IgG-mixed antiglobulin reaction (IgG-MAR [70]), immunobead test (IBT) [71] or sperm-
MAR test [72]. However, none of the available diagnostic tests quantitate, are neither effective
nor specific [73, 74]. Hence, instead of ineffective generalized immunosuppressive therapy
IVF-ICSI should be considered [75–79].
Post vasovasostomy couples are advised IVF for pregnancy depending on body mass index
and age which affect serum testosterone levels as well as ASA in men. In these cases, IVF may
be beneficial only after testing for hypogonadism and serum testosterone levels [80]. ASA post
ASA Body fluid compartment Function Reference
80 kDa protein Serum – [63, 64]
BS 17 – [65]
rSMP-B – – [66]
Acrosin Serum Sperm-oocyte interaction [67]
H-Y antigen Secondary recurrent miscarriage [68]
Table 2. List of autoantigenic targets against sera of women with ASA.
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vasovasostomy can cause necrospermia and deteriorate sperm count hence IVF-ICSI using
testicular sperm is an option [81].
3. Female autoimmune infertility
Women are prone to autoimmune diseases due to hormonally dictated cytokine and chemokine
milieu [82] often leading to other autoimmune dysfunctions [83] including reproductive autoim-
mune failure. Gleicher and co-workers [6] postulated that endometriosis could be an autoim-
mune disease and studies from our lab show 30% prevalence [84]. Commonly seen serum AAbs
are anti-phospholipid, anti-nuclear, anti-thyroid, anti-annexin V, anti-prothrombin, anti-laminin,
anti-ZP (Table 3 for entire list), with the high level of NK cells as the risk factors but not as those
pathognomonic [85]. However, none of the AAb biomarkers tested were effective [86]. A recent
study reported better sensitivity of 6 new biomarkers [87]. With detection of AAbs to steroid
producing cells and thyroglobulin in cases with concomitant adrenal or thyroid disease in PCOS,
it is now considered an autoimmune disease. However, anti-ovarian antibodies were reported in
only one study [7, 88] with no clarity on their role in PCOS pathogenesis [89]. Organ-specific
AAbs such as ovary, adrenal and thyroid (endocrine autoimmune) disease are reported to cause
infertility due to premature ovarian insufficiency (POI) [90].
Both PCOS and endometriosis are also causative factors of POI. 40–60% women with endome-
triosis possess anti-ovarian Abs in addition to anti-endometrial Abs [103]. Several AAbs to
non-organ specific targets are seen in women with unexplained infertility [104]. Further, 22%
of patients with SLE show anti-corpus luteum antibodies and elevated FSH levels typical of
POI [57] and 60% POI cases are of autoimmune origin [105, 106]. POI is typically detected late
with both non-organ and organ-specific antibodies in conjunction with an autoimmune dis-
ease thus evading a specific and accurate biomarker for diagnosis and prognosis [107, 108].
Whether AAbs are causative of or a by-product of underlying disease is unclear.
Nevertheless, elaborate animal models of the disease as well as case studies have provided
relevant data. Day three neonatal thymectomy mouse model showed that multi-organ auto-
immune disease prevails. Immunization with a single antigen causes oophoritis alone while
those to multiple antigens completely compromises ovarian function. Additionally, concomi-
tant presence of the autoantigens was mandatory [109].
Efforts to identify target autoantigens based on discovery of an ovary specific autoantigen by
ELISA, immunofluorescence or immunohistochemistry approach were unfruitful. This inter-
ference was due to non-specific reactivity of natural albumin antibodies [110]. Attempts to
identify target autoantigens using sera and proteomics approach were fruitful enough to
identify several somatic proteins: alpha actin, alpha actinin-4, heat shock proteins 70 and 90β
in 30% of POI and 26% of IVF-ET failure cases [100, 111, 112]. Of these, 47% cases showed
presence of AAbs to HSP90β. Reactivity of these antibodies was seen against several follicular
components (Table 4). Note, besides oocyte the corpus luteum seems to be a major cellular
target while HSP90β the molecular target contributing to early POI (bold and italics in Table 4)
[111]. AAbs to MATER led to assuming it to be an ovary specific target [113] however, these
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AAbs were also seen in idiopathic hypoparathyroidism cases only in context of autoimmune
polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome [114].
Though a 75–90% accuracy was observed in ELISA assays using immunodominant epitopes
from the identified targets, the AAbs were also present in normal population, highlighting the
Autoantibodies Compartment Reference







FSH, β-subunit Serum [9, 12, 91–93]










Cancer antigen 125 (CA125)
Cancer antigen 19.9 (CA19.9)
Serine/threonine-protein kinase (PDIK1L)
Selenium binding protein 1 [96]
Heat-shock protein 90-β Serum [97]
LH receptor [98, 99]
α-Actin Serum [100, 101]
α-Actinin-4
HSPA5 (HSP70)
Stomatin-like protein 2 [84, 87]
Tropomodulin 3 (TMOD3)
Tropomyosin 3 (TPM3)
Double stranded DNA – [89]
Angiotensin II type 1 receptor agonistic autoantibodies Serum [102]
Table 3. List of autoantigenic targets against sera of women with reproductive infertility.
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fact that these were NAbs. These were also validated to induce aPOI in a mouse model. The
immunodominant epitopes tested were able to induce POI and alter ovarian cytoarchitecture.
Folliculogenesis was severely affected at each developmental stage with gross lack of mature
Graafian follicles and a persistent corpus luteum [101].
AAbs to a single immunodominant epitope (EP6) HSP90β led to 9% dissociated oocyte-
cumulus complexes, granulosa cells undergoing apoptosis, 48% empty follicles, and 12%
degenerated follicles. These animals demonstrated significant pre- and post-implantation loss
Condition Age at detection Cellular target Molecular target
POI 22 Oocyte, theca, corpus luteum 90
33 Oocyte, corpus luteum 30
38 45, 90
24 90, 97




33 Ooplasm and nucleus of oocyte, theca
35 Oocyte 55
36 97
35 Oocyte of primordial follicle 70, 75
32 Oocyte 70
35 Granulosa, corpus luteum 30, 45




34 50, 75, 90
30 Oocyte, granulosa 80, 97
28 Oocyte 120
31 Theca 45, 97
29 Oocyte 90, 120
32 30, 50, 90
90
33 Oocyte 90, 97
30 Zona pellucida 45
Table 4. List of antigens and cellular targets detected using sera of women with premature ovarian insufficiency (POI)
and in vitro fertilization-embryo transfer (IVF-ET); compiled from [97].
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with concomitant decrease in fertility index along with an increased polymorphonuclear cell
infiltration of the ovarian follicles. The infiltration may have contributed to generation of
antibodies against the EP6 peptide [115, 116].
In normal physiological inflammatory processes like ovulation, follicular atresia, corpus
luteum regression and tissue remodeling, the ovarian leukocytes like T cells and macrophages
play an important role [117, 118]. Interestingly, NAbs especially, IgM play a role in clearing
apoptotic cells, maintaining B cell homeostasis, inflammation, atherosclerosis and autoimmu-
nity. Any drop in IgM levels is associated with ineffective clearance of apoptotic cells culmi-
nating into autoimmune disease. Alternatively, strong and persistent recognition of apoptotic
cells by such NAbs may overactivate the immune system and cause chronic inflammation [3].
Corticosteroid treatment resolves the ensuing infertility [119]. However, there are no random-
ized controlled trials (RCT) to date. Our animal studies showed high dose corticosteroid was
better able to rescue fertility in mice immunized with immunodominant epitopes of HSPA5
(Table 5). An interesting finding was the epitope spreading observed: AAbs to HSPA5 cross-
react with immunodominant epitope (EP6) of HSP90β at high titer [120]. Thus, autoreactivity
to HSP90β could have diagnostic and prognostic value.
Thyroid autoimmunity is commonly found with other systemic autoimmune diseases [121,
122] and is associated with anti-phospholipid syndrome (APS) due to anti-phospholipid anti-
bodies [123] which in turn mediate recurrent miscarriages common to APS [124]. Thus women
with thyroid autoimmunity and APS have greater risk of recurrent miscarriages mandating
screening for anti-phospholipid antibodies. AAbs to ANA (12%), ANCA (20%), AECA (24%),
ACLA (8%), anti-dsDNA (0%), β2 microglobulin (14%), and anti-HLA antibodies (10%) have
been reported among Indian RSA patients [125]. This indicates that women with thyroiditis,
endometriosis, SLE, APS also run the risk of repeated miscarriages.
At least 20–30% of POI cases have an additional autoimmune disorder [126] including several
endocrinopathies, thyroid diseases, Addison’s disease, rheumatoid arthritis and polyglandular

















30% 24% 32% 44%
HSPA5 Ooplasm, granulosa,
theca and corpus luteum
– 44%
Alpha actin Ooplasm, granulosa and
theca,
30% 36.4%













Table 5. Effect of autoantibodies on fertility and extent of rescue with corticosteroid therapy.
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syndrome with greater prevalence of thyroid autoimmunity (14–27% at initial diagnosis) and
thyroid peroxidase AAbs [127, 128]. At least 10% women with Addison’s disease manifest
AAbs to 21- or 17-hydroxylase and autoimmune oophoritis [129]. Thyroid peroxidase anti-
bodies (TPO Abs) are also prevalent in PCOS cases. Thus, these along with HSP90β could be
included in an antibody detection panel.
In women with endometriosis, use of biomarkers including CA-125 for diagnosis of endome-
triosis was prohibited [130, 131]. However as per recent guidelines, use of biomarkers has been
recommended for both diagnosis and disease monitoring [132] and is still a researchable area.
Anti-endometrial antibodies exist but their sensitivity and accuracy varies from 0 to 100%
[131, 133, 134].
3.1. Treatment modalities and management of autoimmune infertility
Endometriosis management guidelines are valid for women with mild to moderate disease
and do not recommend hormonal therapy for managing ovulation to improve fertility rate
[135]. Despite reduction in ovarian function, one time laparoscopic operation to remove endo-
metriosis and improve pregnancy rates is often recommended [136, 137]. Adjunctive hormonal
therapy is prohibited pre- or post-surgery to improve pregnancy rates [138]. Intra uterine
insemination along with controlled ovarian stimulation is recommended 6 months post-
surgery since it shows similar pregnancy rates as that of women with unexplained infertility
[139]. ART can also be recommended especially in cases of tubal factor or male factor infertility
as controlled ovarian stimulation does not increase chances of recurrence of endometriosis
after IVF/ICSI [140–143] however, it may not always be effective [144, 145].
POI seems to be an end-stage disease in women with an autoimmune disorder since it is
detected at a late stage when the ovary has been substantially ravaged with little scope for
fertility management. Thus treatment options for fertility management of women with POI are
limited. Counseling for early marriage and pregnancy to complete the family is applicable only
in case of early diagnosis or known familial origin. Other options include egg donation and
IVF-ICSI or surrogacy. The women are administered corticosteroids in case of known autoim-
mune disease diagnosis and advised IVF-ICSI when AAb titers fall. However, this is not an
option since it entails risk of osteoporosis and iatrogenic Cushing’s syndrome [119]. In most
cases, adoption is the only option along with psychological counseling and cardiovascular and
bone health management of hypoestrogenism effects [146].
Additionally, there should be efforts to increase awareness among reproductive endocrinolo-
gists to recommend testing for undiagnosed autoimmune disease to couples on a case basis
before embarking on ART-IVF [147].
4. Future research
Presence of AAbs is hallmark of autoimmune disease with no clarity on their role in disease
pathogenesis and ensuing AI. With few exceptions these are not organ-specific indicating them
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to be NAbs [148–151]. Obtaining clarity on role of AAbs will guide further treatment modali-
ties for patients with AI [93, 101, 152]. Global high dose immunosuppressive therapy seems
to be the only effective option for autoimmune reproductive failure despite its shortcomings
[153, 154].
Targeted interventional therapyby inducing antigen-specific tolerance is another option [155, 156].
Till such a time as a definitive therapy is available, pan autoimmune disease diagnostic panels can
be designed using autoantigenic targets (recombinant proteins or peptides) such as β2-glycopro-
tein I and HSP90β (EP6) [151, 157–159] followed by management with corticosteroid therapy. A
loss of reactivity to key autoantigens (predetermined to affect ovarian function) would serve as
biomarkers to better manage immunosuppressant therapy.
5. Conclusion
The very lack of any organ-specific biomarker till date along with the preponderance of NAbs
indicates that warped self-tolerance would lead to AI. AAbs in females alone appear to be
significant in AI. Fertility studies need to be undertaken to gauge effect of such AAbs identi-
fied thus far and immunodominant epitopes gleaned could prove useful to design a pan
autoimmune disease diagnostic peptide array to manage AI. Global immunosuppressant
therapy and IVF-ICSI are the only current hope for such couples.
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